Early Mobility Bundle to Prevent Hospital Acquired Pneumonia (HAP) in Medical Inpatients
Use of Early Mobilisation to Reduce Incidence of Hospital Acquired Pneumonia in Medical Inpatients
Hospital acquired pneumonia (HAP) is a common complication of extended hospital stay. In surgical specialities and critical care early physiotherapy is a recognised way of preventing such infections, and reducing length of hospital stay (LOS), however prevention of this problem is less well studied in medical inpatients.
The investigators propose a pilot study to assess the impact of introducing an early mobilisation strategy to general medical and respiratory wards at an acute Trust in the United Kingdom (UK). The investigators will recruit all new admissions to each of 2 respiratory and 2 elderly care wards - 1 of each ward type will be allocated to receive extra physiotherapy input targeting new admissions for early mobilisation. Patients' usual mobility, current mobility and actual activity levels will be studied by accelerometer and simple patient questionnaire in the first 48 hours of admission, and compared between groups. Incidence of HAP and total LOS will be recorded and compared between groups.
The investigators hypotheses are that the physiotherapy intervention will increase activity levels, reduce incidence of HAP and reduce LOS. The latter may result in cost savings to the National Health Service (NHS), which the investigators will model using local tariff data.
The investigators plan to use our data to power a larger randomised controlled study, or if the intervention is a marked success, such that a control group would be unethical, then a wider service development and evaluation programme.
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
West Midlands
-
Birmingham、West Midlands、イギリス、B9 5SS
- Heart of England NHS Trust
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Any medical inpatient
Exclusion Criteria:
- Nil for main study
- Immobile patients and those unable to consent will be excluded from the sub-study using activity reporting and monitoring by Actigraph
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：非ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Early mobility bundle
Delivery of early targeted physiotherapy to patients on the interventional wards; to comprise assessment and communication of mobility to ward staff and patient, provision of mobility aids, guidance and encouragement to patient and staff to allow patient to dress and mobilise independently if clinically safe to do so
|
|
|
介入なし：Usual care
Usual physiotherapy service only
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of hospital acquired pneumonia
時間枠：Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured, and expressed as incidence/week of stay.
Patients whose length of stay is lower or higher than average will not be excluded.
|
Duration of hospital stay (up to 12 days)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Length of hospital stay in days
時間枠：Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured.
Patients whose length of stay is lower or higher than average will not be excluded
|
Duration of hospital stay (up to 12 days)
|
|
Incidence of falls
時間枠：Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured.
Patients whose length of stay is lower or higher than average will not be excluded
|
Duration of hospital stay (up to 12 days)
|
|
Incidence of pressure area problems
時間枠：Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured.
Patients whose length of stay is lower or higher than average will not be excluded
|
Duration of hospital stay (up to 12 days)
|
その他の成果指標
結果測定 |
時間枠 |
|---|---|
|
Activity levels as reported by patient
時間枠：Days 1 and 2 of admission to ward
|
Days 1 and 2 of admission to ward
|
|
Activity levels as measured by Actigraph
時間枠：Day 1 and 2 of admission to ward
|
Day 1 and 2 of admission to ward
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Alice Turner、University of Birmingham
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Early mobility bundleの臨床試験
-
University of FloridaPerformance Health引きこもった
-
First Affiliated Hospital of Wenzhou Medical UniversityShanghai Zhongshan Hospital; Sir Run Run Shaw Hospital; Wuhan Asia Heart Hospital; Chinese Academy... と他の協力者わからない
-
Saranas, Inc.Cardiovascular Research Foundation, New York; Proxima Clinical Research, Inc.完了
-
University of AdelaideBoston Scientific Corporation; Medtronic; Abbott Medical Devices完了
-
Florida International UniversityNational Institute on Minority Health and Health Disparities (NIMHD)募集
-
Brigham and Women's HospitalBiofourmis Inc.完了
-
Rockfield Medical DevicesHorizon 2020 - European Commission終了しました